Leveraging Genomics to Address Health Disparities in Rare Diseases & Cancer Screenings- C. Jimmy Lin

February 16, 2023 - C. Jimmy Lin, M.D., Ph.D., MHS is the Founder and Chief Executive Officer of Rare Genomics (RG) Institute, an international non-profit founded in 2011 to enable any community to leverage cutting-edge biotechnology to advance understanding of rare diseases. Dr. Lin is also the Chief Scientific Officer at Freenome, working on early diagnostic of cancers. Prior to Freenome, he was the Chief Scientific Officer, Oncology at Natera where he led the development of new diagnostic technologies for cancer.
Before his career in private industry, Dr. Lin led the ClinOmics program at the National Cancer Institute (NIH/NCI) and was a research instructor at Washington University in St. Louis. Dr. Lin earned his MD and PhD from Johns Hopkins School of Medicine and a Master of Health Science from the Johns Hopkins Bloomberg School of Public Health, creating genome-wide maps of breast, colorectal, pancreatic, glioblastoma, medulloblastoma, and melanoma cancers, as well as mapping the genome of an anaerobic bacteria that is used as anti-tumor therapy. He is a 2016 Senior TED Fellow and a 2016 WIRED Innovation Fellow and has been featured in several media outlets, including Forbes, Bloomberg, Wall Street Journal, New York Times, Washington Post, BBC, and TIME Magazine.
About the National Human Genome Research Institute (NHGRI) Division of Intramural Research (DIR) Seminar Series: The NHGRI DIR Seminar Series sponsors a monthly series of talks by intramural and special guest speakers celebrating genetics and genomics research. Speakers are selected by NHGRI intramural faculty and trainees and cover research topics of interest to a wide audience.
Relevant Links:
NHGRI DIR Seminar Series: www.genome.gov/event-calendar...